Facial nerve palsy in the pediatric population.
Shargorodsky
Josef
J
Harvard Medical School, Boston, MA, USA. josef_shargorodsky@meei.harvard.edu
Lin
Harrison W
HW
Gopen
Quinton
Q
D017677:Age Distribution; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use; D015984:Causality; D002648:Child; D002675:Child, Preschool; D004359:Drug Therapy, Combination; D005154:Facial Nerve / Q000503:physiopathology*; D005155:Facial Nerve Diseases / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology; D005158:Facial Paralysis / Q000175:diagnosis* / Q000188:drug therapy / Q000453:epidemiology* / Q000503:physiopathology; D005260:Female; D006801:Humans; D015994:Incidence; D008297:Male; D011379:Prognosis; D020127:Recovery of Function; D018570:Risk Assessment; D012720:Severity of Illness Index; D017678:Sex Distribution; D013256:Steroids / Q000627:therapeutic use; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D000998:Antiviral Agents; D013256:Steroids